A novel adjuvant for mucosal immunity to HIV-1 gp120 in nonhuman primates

Naoto Yoshino, Fabien X S Lü, Kohtaro Fujihashi, Yukari Hagiwara, Kosuke Kataoka, Ding Lu, Linda Hirst, Mitsuo Honda, Frederik W. Van Ginkel, Yoshifumi Takeda, Chris J Miller, Hiroshi Kiyono, Jerry R. McGhee

Research output: Contribution to journalArticle

29 Scopus citations


The development of a safe and effective mucosal adjuvant is a crucial step toward a mucosal HIV/AIDS vaccine. This study seeks to determine the promise of a nontoxic mutant of cholera toxin (mCT; E112K) as a mucosal adjuvant in nonhuman primates. HIV-1 gp120 was nasally administered together with mCT E112K or native CT (nCT) as adjuvant on five to six occasions over a 6- to 8-wk period to groups of four rhesus macaques and alone to two monkeys that acted as controls. Macaques given nasal gp120 with either mCT E112K or nCT showed elevated gp120-specific IgG and IgA Ab responses with virus-neutralizing activity in both their plasma and mucosal external secretions, as well as higher numbers of gp120-specific IgA Ab-forming cells in their mucosal and peripheral lymphoid tissues and of IL-4-producing Th2-type CD4-positive (CD4+) T cells than did controls. Even though significant mucosal adjuvanticity was seen with both mCT E112K and nCT, neuronal damage was observed only in the nCT-treated, but not in the control or mCT E112K-treated groups. These results clearly show that mCT E112K is an effective and safe mucosal adjuvant for the development of a nasal HIV/AIDS vaccine.

Original languageEnglish (US)
Pages (from-to)6850-6857
Number of pages8
JournalJournal of Immunology
Issue number11
StatePublished - Dec 1 2004

ASJC Scopus subject areas

  • Immunology

Fingerprint Dive into the research topics of 'A novel adjuvant for mucosal immunity to HIV-1 gp120 in nonhuman primates'. Together they form a unique fingerprint.

  • Cite this

    Yoshino, N., Lü, F. X. S., Fujihashi, K., Hagiwara, Y., Kataoka, K., Lu, D., Hirst, L., Honda, M., Van Ginkel, F. W., Takeda, Y., Miller, C. J., Kiyono, H., & McGhee, J. R. (2004). A novel adjuvant for mucosal immunity to HIV-1 gp120 in nonhuman primates. Journal of Immunology, 173(11), 6850-6857.